Resumen de Investigación
Analyzed using Evidence Intelligence™

Online Low GI Diet Improves Diabetes Management

Powered by the Dediabetes Evidence Intelligence™ framework

Última actualización 8 de julio de 2026

Key finding

HbA1c decreased from 8.33% to 7.82% (p = 0.001)

This study evaluated the effectiveness of an online low glycemic index diet for managing type 2 diabetes, showing significant improvements in several health markers.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Guarda este estudio en tu Evidence Tracker para encontrarlo facilmente cuando lo necesites.

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

This study evaluated the effectiveness of an online low glycemic index diet for managing type 2 diabetes, showing significant improvements in several health markers.

Clinical relevance

These findings highlight the potential of online dietary interventions in managing type 2 diabetes, offering a practical and accessible approach for patients to improve their health outcomes. The significant reductions in HbA1c and BMI are particularly important as they are associated with lower risks of diabetes complications.

Keep in mind

Limited generalizability due to specific participant characteristics Potential self-reporting bias in dietary adherence Short duration of the intervention may affect long-term applicability

Published in

Referencia de la Revista

Publication details and source links for this paper.

Jinhua C, Lixia L, Xinyi Z, et al. Effectiveness of an Online Low Glycemic Index Diet and Lifestyle Intervention for Type 2 Diabetes Management: A Randomized Controlled Trial. Archives of Public Health. 2025;83:61. doi:10.1186/s13690-025-01552-0

View DOIView on PubMedView on PMC

Efectos Principales

HbA1c decreased from 8.33% to 7.82% (p = 0.001)

BMI decreased from 25.73 kg/m² to 24.35 kg/m² (p < 0.001)

LDL-C decreased from 2.83 mmol/L to 2.38 mmol/L (p < 0.001)

HDL-C increased from 1.21 mmol/L to 1.35 mmol/L (p = 0.001)

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Low glycemic index treatment (LGIT) and BMI, HDL cholesterol, HbA1c, and 2 more.

This study contributes evidence to

Intervention

Low glycemic index treatment (LGIT)

Outcome

BMI

Evidence topic

Dietary Patterns

Primary intervention

Low glycemic index treatment (LGIT)

Primary outcomes

  • BMI
  • HDL cholesterol
  • HbA1c

Evidence topics

Dietary PatternsHbA1c ReductionWeight Loss

Primary intervention

Low glycemic index treatment (LGIT)

Primary outcomes

BMIHDL cholesterolHbA1c

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

5
Evidence pairs
5
Relationships
3
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 72

3

Related topics

5

Evidence pairs

544

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 5 evidence relationships
  • Includes primary outcome data
  • Linked to 3 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Relación de evidencia

Glycemic Control Treatments and Adipokine and Angiogenic Markers

Evidencia relacionada

Relación de evidencia

Glycemic Control Treatments and Body Mass Index

Seguir evidencia

Relación de evidencia

Glycemic Control Treatments and HbA1c

Seguir evidencia

Core evidence

Study findings

The primary outcomes reported in this study.

BMI

Low glycemic index treatment (LGIT) → BMI

Low glycemic index treatment (LGIT) → BMI

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

HbA1c

Low glycemic index treatment (LGIT) → HbA1c

Low glycemic index treatment (LGIT) → HbA1c

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

HDL cholesterol

Low glycemic index treatment (LGIT) → HDL cholesterol

Low glycemic index treatment (LGIT) → HDL cholesterol

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

LDL cholesterol

Low glycemic index treatment (LGIT) → LDL cholesterol

Low glycemic index treatment (LGIT) → LDL cholesterol

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Quality of life

Low glycemic index treatment (LGIT) → Quality of life

Low glycemic index treatment (LGIT) → Quality of life

Evidence Intelligence™
ImpactScore™
25
Negative
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Build your personal Evidence Workspace

Create a free account to save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Today's Activity

Your Evidence Workspace

Free account

Saved this study

Your free account becomes your personal diabetes evidence workspace.

Evidence Tracker

12 tracked topics

Saved Studies

48 studies

Research Notes

Coming Soon

Weekly Evidence Digest

Coming Soon

evidence suggest

La Evidencia Sugiere

  • HbA1c levels significantly decreased by 0.51% (p = 0.001)
  • BMI reduced by 1.38 kg/m² (p < 0.001)
  • LDL-C levels decreased by 0.45 mmol/L (p < 0.001)
who this applies

A quién se aplica

  • Adults diagnosed with type 2 diabetes
  • Individuals seeking dietary interventions for diabetes management
keep in mind

Tener en Cuenta

  • Results may not apply to all demographics or age groups
  • Further studies needed to assess long-term effects
  • Effectiveness may vary based on individual adherence to the diet
between the lines

Entre Líneas

  • Limited generalizability due to specific participant characteristics
  • Potential self-reporting bias in dietary adherence
  • Short duration of the intervention may affect long-term applicability

Save this study

Keep this study in your Evidence Tracker so you can easily find it again whenever you need it.

Today's Activity

Your Evidence Workspace

Free account

Saved this study

Your free account becomes your personal diabetes evidence workspace.

Evidence Tracker

12 tracked topics

Saved Studies

48 studies

Research Notes

Coming Soon

Weekly Evidence Digest

Coming Soon

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Powered by the Dediabetes Evidence Intelligence™ framework

This study contributes to evidence on Glycemic Control Treatments and Body Mass Index, Glycemic Control Treatments and HbA1c.

Relaciones de evidencia relacionadas

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Glycemic Control Treatments affect body mass index?

Emerging Evidence

Glycemic Control Treatments appears to improve Body Mass Index.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    BMI

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
View Full Evidence

Does Glycemic Control Treatments improve adipokine and angiogenic markers?

Emerging Evidence

Glycemic Control Treatments appears to improve Adipokine and Angiogenic Markers.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    HDL cholesterol

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

  2. 2

    LDL cholesterol

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
View Full Evidence

Does Glycemic Control Treatments improve HbA1c?

Emerging Evidence

Glycemic Control Treatments appears to improve HbA1c.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
View Full Evidence

Does Glycemic Control Treatments improve quality of life outcomes?

Emerging Evidence

Glycemic Control Treatments may worsen Quality of Life Outcomes or be associated with harm.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Quality of life

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
View Full Evidence
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

Evidence topics

Follow the topics this study contributes to.

Dietary Patterns Evidence HubHbA1c Reduction Evidence HubWeight Loss Evidence Hub

Explore in archive

Open broader archive views for this relationship.

All studies on Low glycemic index treatment (LGIT) and BMIAll studies on Low glycemic index treatment (LGIT) and HDL cholesterolAll studies on Low glycemic index treatment (LGIT) and HbA1cAll studies on Low glycemic index treatment (LGIT) and LDL cholesterol

Related research

Read related research summaries.

Mediterranean ketogenic eating matched VLCKD for weight loss over 3 monthsGLP-1 agonists reduce heart fat thickness in diabetes.Newer diabetes drugs show stronger weight and blood sugar benefits in prediabetesMobile health support improves blood glucose levels in type 2 diabetesCanagliflozin with metformin reduces cardiovascular risk in T2DM

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.